TP53 status and gene amplification in human colorectal carcinomas

被引:6
作者
Soulié, P
Fourme, E
Hamelin, R
Asselain, B
Salmon, RJ
Dutrillaux, B
Muleris, M
机构
[1] Inst Curie, CNRS UMR147, F-75248 Paris 05, France
[2] Inst Curie, Unite Biostat, F-75248 Paris 05, France
[3] Inst Curie, Dept Surg, F-75248 Paris 05, France
[4] INSERM U434 CEPH, Paris, France
关键词
D O I
10.1016/S0165-4608(99)00073-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gene amplification is one of the characteristics of cancer cells. In vitro studies suggested that alterations of the TP53 gene might be responsible for gene amplification. We have examined the presence of TP53 mutations and looked for cytogenetic evidence of gene amplification in a series of 79 primary colorectal carcinomas. Of her parameters such as the pattern of cytogenetic alterations, microsatellite instability tumor site, and histological staging were of so considered. A multiparametric study supported by statistical analyses suggests the existence of two major path was of colorectal carcinogenesis. No relationships could be established between the presence of TP53 alterations and gene amplification. (C) 1999 Elsevier Science, Inc. All rights reserved.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 50 条
[41]   BSTNI/NCII POLYMORPHISM OF THE HUMAN P53 GENE (TP53) [J].
CHUMAKOV, PM ;
JENKINS, JR .
NUCLEIC ACIDS RESEARCH, 1991, 19 (24) :6969-6969
[42]   BIALLELIC APAI POLYMORPHISM OF THE HUMAN P53-GENE (TP53) [J].
PROSSER, J ;
CONDIE, A .
NUCLEIC ACIDS RESEARCH, 1991, 19 (17) :4799-4799
[44]   Is the TP53 gene the elephant in the room? [J].
Sodhi, Nidhi .
AUSTRALIAN VETERINARY JOURNAL, 2016, 94 (06) :N10-N10
[45]   Clinical impact of TP53 alterations in adrenocortical carcinomas [J].
Waldmann, Jens ;
Patsalis, Nikolaos ;
Fendrich, Volker ;
Langer, Peter ;
Saeger, Wolfgang ;
Chaloupka, Brunhilde ;
Ramaswamy, Annette ;
Fassnacht, Martin ;
Bartsch, Detlef K. ;
Slater, Emily P. .
LANGENBECKS ARCHIVES OF SURGERY, 2012, 397 (02) :209-216
[46]   TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas [J].
Malisic, E. ;
Jankovic, R. ;
Jakovljevic, K. ;
Radulovic, S. .
JOURNAL OF BUON, 2011, 16 (04) :701-707
[47]   TP53 protein expression in colorectal cancer [J].
Ben Ayed, I. ;
Ben Nasr, S. ;
Jaballah-Gabteni, A. ;
Yaiche, H. ;
Ben Jemii, N. ;
Wider, D. ;
Laasili, T. ;
Boubaker, S. ;
Haddauoi, A. ;
Tounsi-Kettiti, H. Guettiti .
ANNALS OF ONCOLOGY, 2023, 34 :S148-S148
[48]   Prevalence of Allelic Loss at TP53 in Endometrial Carcinomas [J].
Semczuk, Andrzej ;
Schneider-Stock, Regine ;
Szewczuk, Wiktor .
ONCOLOGY, 2010, 78 (3-4) :220-228
[49]   Clinical impact of TP53 alterations in adrenocortical carcinomas [J].
Jens Waldmann ;
Nikolaos Patsalis ;
Volker Fendrich ;
Peter Langer ;
Wolfgang Saeger ;
Brunhilde Chaloupka ;
Annette Ramaswamy ;
Martin Fassnacht ;
Detlef K. Bartsch ;
Emily P. Slater .
Langenbeck's Archives of Surgery, 2012, 397 :209-216
[50]   Germline mutations in the TP53 gene [J].
Eeles, RA .
CANCER SURVEYS, 1995, 25 :101-124